Strategic partnerships LAMPIRE has a history of global vendor partnerships with biopharmaceutical, diagnostic, and medical device manufacturers, presenting opportunities to upsell expanded reagent bundles, custom services, and dedicated support agreements to existing collaborators and new OEM customers.

Expanded product suite With capabilities in polyclonal and monoclonal antibody development, secondary antibodies, purified IgGs, human and animal blood products, tissues, and custom conjugation and immunoassay development, there is potential to cross-sell integrated reagent and service packages to research labs, contract research organizations, and diagnostic developers.

Service-led growth LAMPIRE offers peptide synthesis, antigen design, antibody purification, and immunoassay development services, suggesting a strong opportunity for project-based engagements, long-term retainer-based support, and scalable outsourcing partnerships for assay development and optimization.

Geographic & academic reach Recent campus and regional expansion activity, plus collaborations with universities and CROs, indicate potential to target academic labs and regional biotech clusters with training, reagent kits, and collaborative research programs to drive adoption.

Quality and reliability ISO 13485 and ISO 9001 certifications strengthen credibility for regulated markets; leverage this to pursue opportunities in medical device, diagnostic, and pharma manufacturing sectors seeking compliant sourcing, quality agreements, and supplier diversification.